Candid Therapeutics

This early-stage study is testing a new drug called cizutamig in 44 adults with generalized myasthenia gravis, a chronic autoimmune disease that causes severe muscle weakness. The main goal is to check if the drug is safe and well-tolerated, while also looking for early signs tha…

This early-stage study is testing a new drug called CND261 in people with rheumatoid arthritis. The main goal is to check if the drug is safe and how it behaves in the body. About 47 participants with moderate to severe arthritis will receive the drug and be monitored for side ef…

This early-stage study is testing a new drug called cizutamig in people with systemic lupus erythematosus (lupus). The main goal is to check if the drug is safe and how the body handles it, in 47 adults with active lupus. Researchers will monitor side effects and how the drug mov…

This early-stage study aims to measure how much of an experimental drug called cizutamig gets into the bloodstream when given as a simple injection under the skin, compared to an intravenous (IV) drip. Researchers will enroll 20 healthy adult volunteers to receive a single dose b…